Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Lp(a)

Natalie Arnold: The Lp(a) Puzzle - Why Lower Levels May Not Tell the Whole Story
Nov 9, 2026, 10:32 | Voices
Natalie Arnold: The Lp(a) Puzzle - Why Lower Levels May Not Tell the Whole Story
Natalie Arnold, Preventive Cardiologist at University Heart and Vascular Center Hamburg, shared a post on LinkedIn:…
Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
Oct 22, 2026, 14:39 | Science
Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
Mahmoud Abdelnabi, FIT programming Committee at American Heart Association, Assistant Professor at Mayo Clinic, shared…
Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
Oct 6, 2026, 02:18 | Science
Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a…
Heather L. Gornik: Testing for Aortic and Arterial Thrombosis at VSS 2026
Oct 5, 2026, 22:42 | Voices
Heather L. Gornik: Testing for Aortic and Arterial Thrombosis at VSS 2026
Heather L. Gornik, Co-Director of  Vascular Center at University Hospitals, shared a post on X:…
Vishnu Priya Pulipati: The Endocrinologist's Role in Lp(a) and Cardiovascular Risk Reduction
Oct 5, 2026, 10:24 | Science
Vishnu Priya Pulipati: The Endocrinologist's Role in Lp(a) and Cardiovascular Risk Reduction
Vishnu Priya Pulipati, Founder and Host of LipidCurious Podcast, Member of Institutional Review Ethics Board…
William Wallace: Your Cholesterol Test is Missing a Particle that May Matter More than the One it Measures
Sep 28, 2026, 19:02 | Voices
William Wallace: Your Cholesterol Test is Missing a Particle that May Matter More than the One it Measures
William Wallace, Co-Founder and Chief Scientific Officer at Supplement Success Solutions, shared a post on…
Rafael Zubiran: High Lp(a) Drives 1 in 15 Cases of Aortic Stenosis
Sep 28, 2026, 14:30 | Science
Rafael Zubiran: High Lp(a) Drives 1 in 15 Cases of Aortic Stenosis
Rafael Zubiran, Postdoctoral Researcher at National Heart, Lung, and Blood Institute, shared a post on…
Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
Sep 27, 2026, 15:46 | Voices
Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
Franck Perraudin, VP - Cardiovascular TA Head International Commercial and Launch Strategy at Novartis, shared…
Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
Sep 22, 2026, 08:50 | Science
Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
Emily Horner, British Heart Foundation PhD Researcher at University of Leeds, shared a post on…
George Touma: ApoB Should Be Central to All Lipid Guidlines
Sep 21, 2026, 20:56 | Voices
George Touma: ApoB Should Be Central to All Lipid Guidlines
George Touma, Interventional Cardiologist at St George Private Cardiology, shared a post on LinkedIn: "ApoB…
Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
Sep 18, 2026, 13:38 | Science
Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
Sam Tsimikas, Professor of Medicine at the University of California, San Diego, shared a post…
Thomas Dayspring - Your LDL Is Normal - But Are You Really Safe?
Sep 16, 2026, 04:58 | Voices
Thomas Dayspring - Your LDL Is Normal - But Are You Really Safe?
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn: "This for sure…
Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
Sep 13, 2026, 16:52 | Science
Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
Kaloyan Takov, Research Associate at Imperial College London, shared a post on LinkedIn about a…
Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
Sep 12, 2026, 17:51 | Voices
Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn: "In…
Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
Sep 11, 2026, 09:51 | Voices
Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?
Alfredo Lozada, Founder of Clinica del Colesterol at Cholesterol Clinic, shared a post on LinkedIn:…
J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
Sep 10, 2026, 21:33 | Voices
J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
J. Meireles-Brandao, SEDES – Association for Economic and Social Development at Associado, shared a post…
Natalie Arnold: Biomarkers and the Hidden Burden of CHD
Sep 9, 2026, 13:59 | Science
Natalie Arnold: Biomarkers and the Hidden Burden of CHD
Natalie Arnold, Preventive Cardiologist at University Heart and Vascular Center Hamburg, shared a post on LinkedIn about…
Nicolas Federico Renna: When Biomarkers Fall but Cardiovascular Events Do Not
Sep 9, 2026, 12:58 | Voices
Nicolas Federico Renna: When Biomarkers Fall but Cardiovascular Events Do Not
Nicolas Federico Renna, Fellow of the International Society of Hypertension, Adjunct Professor of Medicine at…
Roman Rodionov: Is Lp(a) Another Homocysteine?
Sep 8, 2026, 13:12 | Voices
Roman Rodionov: Is Lp(a) Another Homocysteine?
Roman Rodionov, Senior Consultant (Internal and Vascular Medicine, Apheresis), Head of the Angiology Research Lab…
Davide Capodanno: Lp(a) After HORIZON and the Outcome Question
Sep 7, 2026, 14:27 | Voices
Davide Capodanno: Lp(a) After HORIZON and the Outcome Question
Davide Capodanno, Professor of Cardiology at University of Catania, shared a post on X: ''The…
Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
Aug 31, 2026, 17:01 | Voices
Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
Mark Kaplan, Managing Partner, Co-Founder of Paradigm Capital International, MD, International Distribution at SaveDaily, Head…
J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
Aug 30, 2026, 17:13 | Science
J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
J. Meireles-Brandao, SEDES – Association for Economic and Social Development at Associado, shared a post…
Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
Aug 20, 2026, 19:44 | Science
Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
Harshi Peiris, Science Writer and Communicator, shared JAMA's post on X: "Big update in heart…
Faris Al-Radi: A Masterclass in Lipidology From ApoB to Lp(a) and Beyond
Aug 17, 2026, 07:34 | Voices
Faris Al-Radi: A Masterclass in Lipidology From ApoB to Lp(a) and Beyond
Faris Al-Radi, Internal Medicine Specialist at Mediclinic Middle East, shared a post on LinkedIn: "Dr…
Atul V Kumar: Why Normal Cholesterol Does Not Guarantee Heart Health
Aug 12, 2026, 15:22 | Insight
Atul V Kumar: Why Normal Cholesterol Does Not Guarantee Heart Health
Atul V Kumar, Senior Consultant at Max heart and vascular Institute,saket, New Delhi, shared a…
Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
Aug 9, 2026, 09:29 | Science
Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
Michael Wilkinson, Associate Professor of Medicine at UC San Diego Health, shared a post on LinkedIn about…
Pablo Corral: Viewing Lp(a) as a Multidimensional Particle
Aug 4, 2026, 02:12 | Voices
Pablo Corral: Viewing Lp(a) as a Multidimensional Particle
Thomas Dayspring, Fellow of the American College of Physicians (FACP) and the National Lipid Association…
Wolfgang Miesbach: First Lp(a)‑Specific Therapy in Secondary Prevention?
May 19, 2026, 14:53 | Science
Wolfgang Miesbach: First Lp(a)‑Specific Therapy in Secondary Prevention?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about…
Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
May 12, 2026, 15:57 | Science
Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article…
Seyed Amir Raoufi: The Growing Role of CAC and Lp(a) in Preventive Cardiology
May 11, 2026, 13:29 | Voices
Seyed Amir Raoufi: The Growing Role of CAC and Lp(a) in Preventive Cardiology
Seyed Amir Raoufi, Interventional Cardiologist, shared a post on LinkedIn: "1. Patient Profile ​ Age/Gender: middle…
Anna Gardin: Incredible Initiative to Measure Clinician's Own Lp(a) On The Spot at ESOC 2026
May 9, 2026, 14:17 | Voices
Anna Gardin: Incredible Initiative to Measure Clinician's Own Lp(a) On The Spot at ESOC 2026
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, shared on LinkedIn: ''At…
Charlie Windri: CAC as the Missing Link in Lp(a) Risk
Apr 16, 2026, 02:57 | Voices
Charlie Windri: CAC as the Missing Link in Lp(a) Risk
Charlie Windri, Laboratory Specialist at FHI 360, Clinical Pathologist at Laboratorium Dia Care Pasar Minggu,…
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Apr 1, 2026, 17:21 | Science
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Antonio Pineda Guerrero, Research Trainee at INIT-UJI, shared a post on LinkedIn about a recent…
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Mar 30, 2026, 17:25 | Science
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Maria Angelica Pabon, Cardiologist at Brigham and Women's Hospital, shared on LinkedIn about a recent article…
Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
Mar 27, 2026, 16:23 | Voices
Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
Nathan Wong, Professor and Director of the Heart Disease Prevention Program, Division of Cardiology at…
Lorenz Räber: New Insights Into Silent Plaque Ruptures in AMI Patients
Mar 14, 2026, 15:37 | Science
Lorenz Räber: New Insights Into Silent Plaque Ruptures in AMI Patients
Lorenz Räber, Vice President of Swiss Society of Cardiology, shared a post on LinkedIn about…
Jim Hoffman: Exploring Extracorporeal Strategies to Target NETs in Cardiovascular Disease
Mar 9, 2026, 15:25 | Science
Jim Hoffman: Exploring Extracorporeal Strategies to Target NETs in Cardiovascular Disease
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Apherese ForschungsInstitut - AFI's post…
Vallabh Janardhan: Vascular Disease Is Ultimately A Story of Thrombosis
Feb 22, 2026, 07:46 | Voices
Vallabh Janardhan: Vascular Disease Is Ultimately A Story of Thrombosis
Vallabh Janardhan, Co-Founder and CMO at Insera Therapeutics, Inc., shared on LinkedIn: ''Dallas CV Updates…
Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
Jan 27, 2026, 13:48 | Science
Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
Filippo Cademartiri, Consultant Advanced Cardiovascular Imaging at UPMC Salvator Mundi International Hospital, shared on LinkedIn:…
Maciej Banach Shares Insights From the STAR-Lp(a) Study
Dec 28, 2025, 14:12 | Science
Maciej Banach Shares Insights From the STAR-Lp(a) Study
Maciej Banach, Vice-Rector for the Collegium Medicum at John Paul II Catholic University of Lublin,…
Federica Fogacci: Lp(a) Doesn’t Simply Add Risk - It Reframes Risk
Dec 22, 2025, 12:31 | Science
Federica Fogacci: Lp(a) Doesn’t Simply Add Risk - It Reframes Risk
Federica Fogacci, Editorial Board member and Social Media Editor at Atherosclerosis, shared on LinkedIn: "Lp(a)…
Lp(a) Testing in Primary Prevention: Cost-Effective Strategy to Reduce Cardiovascular Risk
Sep 14, 2025, 14:36 | Science
Lp(a) Testing in Primary Prevention: Cost-Effective Strategy to Reduce Cardiovascular Risk
Atherosclerosis has shared a post on LinkedIn: “Lp(a) Testing: A Cost-Saving Tool for Cardiovascular Prevention High…
Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention
Aug 28, 2025, 19:00 | Insight
Zanfina Ademi: Routine Lp(a) Testing as a Cost-Effective Step Toward Precision Cardiovascular Prevention
FH Europe Foundation shared an insightful post from Professor Zanfina Ademi on LinkedIn: "Lp(a): A…
All: 43 Posts: 1 - 100
NewsFeed